FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Dean Wingerchuk

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Physiology

Disease Progression

Procedures

Anatomy

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Dean M Wingerchuk
"Response to the commentary on "neuromyelitis optica: potential roles for intravenous immunoglobulin"".
Thomas P Bravo; Bart M Demaerschalk; Matthew T Hoerth; Charlene R Hoffman-Snyder; Kari A Martin; Kay E Wellik; Dean M Wingerchuk
The effect of selective serotonin reuptake inhibitors on the frequency of psychogenic nonepileptic seizures: a critically appraised topic.
Dean M Wingerchuk
Neuromyelitis optica: potential roles for intravenous immunoglobulin.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Dean Wingerchuk (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Dean M Wingerchuk
"Response to the commentary on "neuromyelitis optica: potential roles for intravenous immunoglobulin"".
Journal of clinical immunology 2013;33(2):308.
2013: Thomas P Bravo; Bart M Demaerschalk; Matthew T Hoerth; Charlene R Hoffman-Snyder; Kari A Martin; Kay E Wellik; Dean M Wingerchuk
The effect of selective serotonin reuptake inhibitors on the frequency of psychogenic nonepileptic seizures: a critically appraised topic.
The neurologist 2013;19(1):30-3.
2013: Dean M Wingerchuk
Neuromyelitis optica: potential roles for intravenous immunoglobulin.
Journal of clinical immunology 2013;33 Suppl 1():S33-7.
2012: Gretchen E Schlosser Covell; Kay E Wellik; Dean M Wingerchuk; Bryan Woodruff; Richard Caselli; Priya S Dhawan; Charlene R Hoffman-Snyder; Joyce K Lee Iannotti; Bart M Demaerschalk
Disrupted daytime activity and altered sleep-wake patterns may predict transition to mild cognitive impairment or dementia: a critically appraised topic.
The neurologist 2012;18(6):426-9.
2012: Scott D Spritzer; Kay E Wellik; Richard S Zimmerman; Bart M Demaerschalk; Matthew T Hoerth; Charlene R Hoffman-Snyder; Aaron Shmookler; Dean M Wingerchuk
Determination of hemispheric language dominance in the surgical epilepsy patient: diagnostic properties of functional magnetic resonance imaging.
The neurologist 2012;18(5):329-31.
2012: Maureen A Mealy; Dean M Wingerchuk; Benjamin M Greenberg; Michael Levy
Epidemiology of neuromyelitis optica in the United States: a multicenter analysis.
Archives of neurology 2012;69(9):1176-80.
2012: Amy M L Quek; Elizabeth A Shuster; Brian G Weinshenker; Dean M Wingerchuk; Chiara Costanzi; Raffaele Iorio; Yujuan Jiao; Vanda A Lennon; Claudia F Lucchinetti; Jayawant N Mandrekar; Andrew McKeon; Sean J Pittock
Effects of age and sex on aquaporin-4 autoimmunity.
Archives of neurology 2012;69(8):1039-43.
2012: Joyce K Lee-Iannotti; Bhavesh Patel; Fernando Tondato; Kay E Wellik; Dean M Wingerchuk; Dan J Capampangan; Charlene Hoffman Snyder; Bart M Demaerschalk
New-onset atrial fibrillation in severe sepsis and risk of stroke and death: a critically appraised topic.
The neurologist 2012;18(4):239-43.
2012: Christopher Kramer; Joel S Larson; Kay E Wellik; Bart M Demaerschalk; William D Freeman; Charlene Hoffman Snyder; Dean M Wingerchuk
Therapeutic hypothermia for severe traumatic brain injury: a critically appraised topic.
The neurologist 2012;18(3):173-7.
2012: Amelia K Adcock; Maria I Aguilar; Charlene R Hoffman-Snyder; Joyce K Lee-Iannotti; Kay E Wellik; Dean M Wingerchuk; Bart M Demaerschalk
Is dabigatran cost effective compared with warfarin for stroke prevention in atrial fibrillation? A critically appraised topic.
The neurologist 2012;18(2):102-7.
2012: Dean M Wingerchuk
Smoking: effects on multiple sclerosis susceptibility and disease progression.
Therapeutic advances in neurological disorders 2012;5(1):13-22.
2012: Dean M Wingerchuk; Brian G Weinshenker
The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease.
Multiple sclerosis (Houndmills, Basingstoke, England) 2012;18(1):5-10.
2011: Dean M Wingerchuk; Brian G Weinshenker
White matter disease: optimizing rituximab therapy for neuromyelitis optica.
Nature reviews. Neurology 2011;7(12):664-5.
2011: Christopher Kramer; Kay E Wellik; Dean M Wingerchuk; Maria I Aguilar; Charlene Hoffman Snyder; Bart M Demaerschalk
Safety and efficacy of ultrasound-enhanced thrombolysis in the treatment of acute middle cerebral artery infarction: a critically appraised topic.
The neurologist 2011;17(6):346-51.
2011: Amaal J Starling; Bert B Vargas; Kay E Wellik; Bart M Demaerschalk; David W Dodick; Rashmi B Halker; Charlene Hoffman Snyder; Dean M Wingerchuk
Risk of development of medication overuse headache with nonsteroidal anti-inflammatory drug therapy for migraine: a critically appraised topic.
The neurologist 2011;17(5):297-9.
2011: Roberto Bomprezzi; J Michael Powers; Jun Shimizu; Shoji Tsuji; Brian G Weinshenker; Dean M Wingerchuk
IFNβ-1b may severely exacerbate Japanese opticspinal MS in neuromyelitis optica spectrum: Japanese optic-spinal MS: is it MS or neuromyelitis optica and does the answer dictate treatment?
Neurology 2011;77(2):195; discussion 195-6.
2011: Dean M Wingerchuk; Brian G Weinshenker
Lupus related longitudinal myelitis.
The Journal of rheumatology 2011;38(7):1520; author reply 1521.
2011: Cumara B O'Carroll; Kay E Wellik; Dean M Wingerchuk; Charlene R Hoffman-Snyder; Maria I Aguilar; Thomas P Bravo; Dan J Capampangan; Bart M Demaerschalk
What is the effect of low-molecular weight heparin for venous thromboembolism prophylaxis compared with mechanical methods, on the occurrence of hemorrhagic and venous thromboembolic complications in patients with intracerebral hemorrhage? A critically appraised topic.
The neurologist 2011;17(4):232-5.
2011: Kristine S Ziemba; Kay E Wellik; Charlene Hoffman Snyder; Katherine H Noe; Bart M Demaerschalk; Dean M Wingerchuk
Timing of antiepileptic drug withdrawal in adult epilepsy patients after neocortical surgical resection: a critically appraised topic.
The neurologist 2011;17(3):176-8.
2011: Dean M Wingerchuk
Environmental factors in multiple sclerosis: Epstein-Barr virus, vitamin D, and cigarette smoking.
The Mount Sinai journal of medicine, New York 2011;78(2):221-30.
2011: Katherine C Riordan; Charlene Hoffman Snyder; Kay E Wellik; Richard Caselli; Dean M Wingerchuk; Bart M Demaerschalk
Effectiveness of adding memantine to an Alzheimer dementia treatment regimen which already includes stable donepezil therapy: a critically appraised topic.
The neurologist 2011;17(2):121-3.
2011: Amaal J Starling; Kay E Wellik; Charlene Hoffman Snyder; Maria I Aguilar; Bart M Demaerschalk; Richard S Zimmerman; Dean M Wingerchuk
Surgical decompression improves mortality and morbidity after large territory acute cerebral infarction: a critically appraised topic.
The neurologist 2011;17(1):63-6.
2010: Katherine C Riordan; Dean M Wingerchuk; Kay E Wellik; Richard S Zimmerman; Joseph I Sirven; Katherine H Noe; Bhavesh M Patel; Bart M Demaerschalk
Anticonvulsant drug therapy after aneurysmal subarachnoid hemorrhage: a critically appraised topic.
The neurologist 2010;16(6):397-9.
2010: Brian G Weinshenker; Dean M Wingerchuk
Japanese optic-spinal MS: is it MS or neuromyelitis optica and does the answer dictate treatment?
Neurology 2010;75(16):1404-5.
2010: Dean M Wingerchuk
Neuromyelitis optica spectrum disorders.
Continuum (Minneapolis, Minn.) 2010;16(5 Multiple Sclerosis):105-21.
2010: Richard Caselli; Joseph F Drazkowski; Dean M Wingerchuk
Autoimmune encephalopathy.
Mayo Clinic proceedings. Mayo Clinic 2010;85(10):878-80.
2010: Kristine S Ziemba; Cumara B O'Carroll; Joseph F Drazkowski; Dean M Wingerchuk; Charlene Hoffman Snyder; Kay E Wellik; Bart M Demaerschalk
Do antiepileptic drugs increase the risk of suicidality in adult patients with epilepsy?: a critically appraised topic.
The neurologist 2010;16(5):325-8.
2010: Elliot M Frohman; Dean M Wingerchuk
Clinical practice. Transverse myelitis.
The New England journal of medicine 2010;363(6):564-72.
2010: Dan J Capampangan; Kay E Wellik; James M Parish; Maria I Aguilar; Charlene R Hoffman Snyder; Dean M Wingerchuk; Bart M Demaerschalk
Is obstructive sleep apnea an independent risk factor for stroke? A critically appraised topic.
The neurologist 2010;16(4):269-73.
2010: Dean M Wingerchuk
Supplementing our understanding of vitamin D and multiple sclerosis.
Neurology 2010;74(23):1846-7.
2010: Srijana Zarkou; Jonathan L Carter; Kay E Wellik; Bart M Demaerschalk; Dean M Wingerchuk
Are corticosteroids efficacious for preventing or treating neutralizing antibodies in multiple sclerosis patients treated with beta-interferons? A critically appraised topic.
The neurologist 2010;16(3):212-4.
2010: Greg M Thaera; Kay E Wellik; David M Barrs; Erika D Driver Dunckley; Dean M Wingerchuk; Bart M Demaerschalk
Are corticosteroid and antiviral treatments effective for bell palsy? A critically appraised topic.
The neurologist 2010;16(2):138-40.
2010: Ales Hlubocky; Kay Wellik; Mark A Ross; Benn E Smith; Charlene Hoffman Snyder; Bart M Demaerschalk; Dean M Wingerchuk
Skin biopsy for diagnosis of small fiber neuropathy: a critically appraised topic.
The neurologist 2010;16(1):61-3.
2009: Dean M Wingerchuk
Neuromyelitis optica: effect of gender.
Journal of the neurological sciences 2009;286(1-2):18-23.
2009: Greg M Thaera; Kay E Wellik; Jonathan L Carter; Bart M Demaerschalk; Dean M Wingerchuk
Do cannabinoids reduce multiple sclerosis-related spasticity?
The neurologist 2009;15(6):369-71.
2009: McKeon Andrew; James P Fryer; Metha Apiwattanakul; Vanda A Lennon; Shannon R Hinson; Thomas J Kryzer; Claudia F Lucchinetti; Brian G Weinshenker; Dean M Wingerchuk; Elizabeth A Shuster; Sean J Pittock
Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays.
Archives of neurology 2009;66(9):1134-8.
2009: Anu Jacob; Marcelo Matiello; Brian G Weinshenker; Dean M Wingerchuk; Claudia F Lucchinetti; Elizabeth Shuster; Jonathan Carter; B Mark Keegan; Orhun H Kantarci; Sean J Pittock
Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients.
Archives of neurology 2009;66(9):1128-33.
2009: Srijana Zarkou; Maria I Aguilar; Naresh P Patel; Kay E Wellik; Dean M Wingerchuk; Bart M Demaerschalk
The role of corticosteroids in the management of chronic subdural hematomas: a critically appraised topic.
The neurologist 2009;15(5):299-302.
2009: Amy C Almaraz; Erika D Driver-Dunckley; Bryan Woodruff; Kay E Wellik; Richard Caselli; Bart M Demaerschalk; Charles H Adler; John Caviness; Dean M Wingerchuk
Efficacy of rivastigmine for cognitive symptoms in Parkinson disease with dementia.
The neurologist 2009;15(4):234-7.
2009: Dan J Capampangan; Kay E Wellik; Bentley J Bobrow; Maria I Aguilar; Timothy J Ingall; Terri-Ellen Kiernan; Dean M Wingerchuk; Bart M Demaerschalk
Telemedicine versus telephone for remote emergency stroke consultations: a critically appraised topic.
The neurologist 2009;15(3):163-6.
2009: Julie Khoury; Kay E Wellik; Bart M Demaerschalk; Dean M Wingerchuk
Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of central nervous system sarcoidosis.
The neurologist 2009;15(2):108-11.
2009: Amy C Almaraz; Bentley J Bobrow; Dean M Wingerchuk; Kay E Wellik; Bart M Demaerschalk
Serum neuron specific enolase to predict neurological outcome after cardiopulmonary resuscitation: a critically appraised topic.
The neurologist 2009;15(1):44-8.
2009: Katherine Arendt; Bart M Demaerschalk; Dean M Wingerchuk; William Camann
Atraumatic lumbar puncture needles: after all these years, are we still missing the point?
The neurologist 2009;15(1):17-20.
2008: Dan J Capampangan; Kay E Wellik; Maria I Aguilar; Bart M Demaerschalk; Dean M Wingerchuk
Does prophylactic postoperative hypervolemic therapy prevent cerebral vasospasm and improve clinical outcome after aneurysmal subarachnoid hemorrhage?
The neurologist 2008;14(6):395-8.
2008: Anu Jacob; Brian G Weinshenker; Ivo Violich; Nancy McLinskey; Lauren Krupp; Robert J Fox; Dean M Wingerchuk; Mike Boggild; Cris S Constantinescu; Aaron Miller; Tracy De Angelis; Marcelo Matiello; Bruce A C Cree
Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients.
Archives of neurology 2008;65(11):1443-8.
2008: Bert B Vargas; David W Dodick; Dean M Wingerchuk; Bart M Demaerschalk
Migraine with and without aura and risk for cardiovascular disease.
Current atherosclerosis reports 2008;10(5):427-33.
2008: Julie A Khoury; Joseph M Hoxworth; Mehrdad Mazlumzadeh; Kay E Wellik; Dean M Wingerchuk; Bart M Demaerschalk
The clinical utility of high resolution magnetic resonance imaging in the diagnosis of giant cell arteritis: a critically appraised topic.
The neurologist 2008;14(5):330-5.
2008: Matthew T Hoerth; Kay E Wellik; Bart M Demaerschalk; Joseph F Drazkowski; Katherine H Noe; Joseph I Sirven; Dean M Wingerchuk
Clinical predictors of psychogenic nonepileptic seizures: a critically appraised topic.
The neurologist 2008;14(4):266-70.
2008: M Matiello; Vanda A Lennon; A Jacob; Sean J Pittock; Claudia F Lucchinetti; Dean M Wingerchuk; Brian G Weinshenker
NMO-IgG predicts the outcome of recurrent optic neuritis.
Neurology 2008;70(23):2197-200.
2008: Dean M Wingerchuk; P James B Dyck; Lester E Mertz
Hemi-meningitis: A focal sign heralding a multisystem necrotizing vasculitis.
Neurology 2008;70(21):2014.
2008: Rashmi B Halker; David M Barrs; Kay E Wellik; Dean M Wingerchuk; Bart M Demaerschalk
Establishing a diagnosis of benign paroxysmal positional vertigo through the dix-hallpike and side-lying maneuvers: a critically appraised topic.
The neurologist 2008;14(3):201-4.
2008: Sara L P Schrader; Kay E Wellik; Bart M Demaerschalk; Richard Caselli; Bryan Woodruff; Dean M Wingerchuk
Adjunctive haloperidol prophylaxis reduces postoperative delirium severity and duration in at-risk elderly patients.
The neurologist 2008;14(2):134-7.
2008: Dean M Wingerchuk
Current evidence and therapeutic strategies for multiple sclerosis.
Seminars in neurology 2008;28(1):56-68.
2008: Dean M Wingerchuk; Brian G Weinshenker
Neuromyelitis optica.
Current treatment options in neurology 2008;10(1):55-66.
2008: Brian G Weinshenker; Dean M Wingerchuk
Neuromyelitis optica: clinical syndrome and the NMO-IgG autoantibody marker.
Current topics in microbiology and immunology 2008;318():343-56.
2008: Madeline L Miley; Kay E Wellik; Dean M Wingerchuk; Bart M Demaerschalk
Does cervical manipulative therapy cause vertebral artery dissection and stroke?
The neurologist 2008;14(1):66-73.
2008: Sean J Pittock; Vanda A Lennon; Jérôme de Seze; Patrick Vermersch; Henry A Homburger; Dean M Wingerchuk; Claudia F Lucchinetti; Hélène Zéphir; Kevin G Moder; Brian G Weinshenker
Neuromyelitis optica and non organ-specific autoimmunity.
Archives of neurology 2008;65(1):78-83.
2007: Jonathan H McKinnon; Bart M Demaerschalk; John Caviness; Kay E Wellik; Charles H Adler; Dean M Wingerchuk
Sniffing out Parkinson disease: can olfactory testing differentiate parkinsonian disorders?
The neurologist 2007;13(6):382-5.
2007: Rashmi B Halker; Bart M Demaerschalk; Kay E Wellik; Dean M Wingerchuk; Devon I Rubin; Brian A Crum; David W Dodick
Caffeine for the prevention and treatment of postdural puncture headache: debunking the myth.
The neurologist 2007;13(5):323-7.
2007: Dean M Wingerchuk; Vanda A Lennon; Claudia F Lucchinetti; Sean J Pittock; Brian G Weinshenker
The spectrum of neuromyelitis optica.
Lancet neurology 2007;6(9):805-15.
2007: Bart M Demaerschalk; Dean M Wingerchuk
The MERITs of evidence-based clinical practice in neurology.
Seminars in neurology 2007;27(4):303-11.
2007: Dean M Wingerchuk; Byron Spencer; David W Dodick; Bart M Demaerschalk
Migraine with aura is a risk factor for cardiovascular and cerebrovascular disease: a critically appraised topic.
The neurologist 2007;13(4):231-3.
2007: Anu Jacob; Marcelo Matiello; Dean M Wingerchuk; Claudia F Lucchinetti; Sean J Pittock; Brian G Weinshenker
Neuromyelitis optica: changing concepts.
Journal of neuroimmunology 2007;187(1-2):126-38.
2007: Dean M Wingerchuk; Claudia F Lucchinetti
Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis.
Current opinion in neurology 2007;20(3):343-50.
2007: Marcelo Matiello; Anu Jacob; Dean M Wingerchuk; Brian G Weinshenker
Neuromyelitis optica.
Current opinion in neurology 2007;20(3):255-60.
2007: Junger Tang; Dean M Wingerchuk; Brian A Crum; Devon I Rubin; Bart M Demaerschalk
Alpha-lipoic acid may improve symptomatic diabetic polyneuropathy.
The neurologist 2007;13(3):164-7.
2007: Shanu F Roemer; Joseph E Parisi; Vanda A Lennon; Eduardo E Benarroch; Hans Lassmann; Wolfgang Bruck; Raul N Mandler; Brian G Weinshenker; Sean J Pittock; Dean M Wingerchuk; Claudia F Lucchinetti
Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
Brain : a journal of neurology 2007;130(Pt 5):1194-205.
2007: Mark G Hickey; Bart M Demaerschalk; Richard Caselli; James M Parish; Dean M Wingerchuk
"Idiopathic" rapid-eye-movement (REM) sleep behavior disorder is associated with future development of neurodegenerative diseases.
The neurologist 2007;13(2):98-101.
2007: Dean M Wingerchuk; Sean J Pittock; Claudia F Lucchinetti; Vanda A Lennon; Brian G Weinshenker
A secondary progressive clinical course is uncommon in neuromyelitis optica.
Neurology 2007;68(8):603-5.
2007: Dean M Wingerchuk
Neuromyelitis optica: new findings on pathogenesis.
International review of neurobiology 2007;79():665-88.
2007: Joseph I Sirven; Terry Douglas Fife; Dean M Wingerchuk; Joseph F Drazkowski
Second-generation antiepileptic drugs' impact on balance: a meta-analysis.
Mayo Clinic proceedings. Mayo Clinic 2007;82(1):40-7.
2007: Bart M Demaerschalk; Dean M Wingerchuk
Treatment of vascular dementia and vascular cognitive impairment.
The neurologist 2007;13(1):37-41.
2007: Dean M Wingerchuk
Diagnosis and treatment of neuromyelitis optica.
The neurologist 2007;13(1):2-11.
2007: Dean M Wingerchuk; Bart M Demaerschalk
Critically appraised topics: the evidence-based neurologist.
The neurologist 2007;13(1):1.
2006: Alyx Porter; Mark K Lyons; Dean M Wingerchuk; E Peter Bosch
Spinal cord astrocytoma presenting as "idiopathic" intracranial hypertension.
Clinical neurology and neurosurgery 2006;108(8):787-9.
2006: Dean M Wingerchuk; Moses Rodriguez
Premenstrual multiple sclerosis pseudoexacerbations: Role of body temperature and prevention with aspirin.
Archives of neurology 2006;63(7):1005-8.
2006: Sean J Pittock; Brian G Weinshenker; Claudia F Lucchinetti; Dean M Wingerchuk; John R Corboy; Vanda A Lennon
Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.
Archives of neurology 2006;63(7):964-8.
2006: Orhun Kantarci; Dean M Wingerchuk
Epidemiology and natural history of multiple sclerosis: new insights.
Current opinion in neurology 2006;19(3):248-54.
2006: Dean M Wingerchuk; Vanda A Lennon; Sean J Pittock; Claudia F Lucchinetti; Brian G Weinshenker
Revised diagnostic criteria for neuromyelitis optica.
Neurology 2006;66(10):1485-9.
2006: Dean M Wingerchuk
Evidence for humoral autoimmunity in neuromyelitis optica.
Neurological research 2006;28(3):348-53.
2006: Dean M Wingerchuk
The clinical course of acute disseminated encephalomyelitis.
Neurological research 2006;28(3):341-7.
2006: Sean J Pittock; Brian G Weinshenker; John H Noseworthy; Claudia F Lucchinetti; Mark Keegan; Dean M Wingerchuk; Jonathan Carter; Elizabeth Shuster; Moses Rodriguez
Not every patient with multiple sclerosis should be treated at time of diagnosis.
Archives of neurology 2006;63(4):611-4.
2006: Sean J Pittock; Vanda A Lennon; Karl Krecke; Dean M Wingerchuk; Claudia F Lucchinetti; Brian G Weinshenker
Brain abnormalities in neuromyelitis optica.
Archives of neurology 2006;63(3):390-6.
2006: Dean M Wingerchuk
Multiple sclerosis disease-modifying therapies: adverse effect surveillance and management.
Expert review of neurotherapeutics 2006;6(3):333-46.
2006: Brian G Weinshenker; Dean M Wingerchuk; Sandra Vukusic; Linda Linbo; Sean J Pittock; Claudia F Lucchinetti; Vanda A Lennon
Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis.
Annals of neurology 2006;59(3):566-9.
2006: Brian G Weinshenker; Dean M Wingerchuk; Ichiro Nakashima; Kazuo Fujihara; Vanda A Lennon
OSMS is NMO, but not MS: proven clinically and pathologically.
Lancet neurology 2006;5(2):110-1.
2006: Brian G Weinshenker; Dean M Wingerchuk; Sean J Pittock; Claudia F Lucchinetti; Vanda A Lennon
NMO-IgG: a specific biomarker for neuromyelitis optica.
Disease markers 2006;22(4):197-206.
2006: Dean M Wingerchuk
Neuromyelitis optica.
Advances in neurology 2006;98():319-33.
2006: Dean M Wingerchuk
Acute disseminated encephalomyelitis: distinction from multiple sclerosis and treatment issues.
Advances in neurology 2006;98():303-18.
2005: Bruce A C Cree; Dean M Wingerchuk
Acute transverse myelitis: is the "idiopathic" form vanishing?
Neurology 2005;65(12):1857-8.
2005: Dean M Wingerchuk; N P Patel; A C Patel; David W Dodick; K D Nelson
Progressive cervical myelopathy secondary to chronic ventriculoperitoneal CSF overshunting.
Neurology 2005;65(1):171-2.
2005: Dean M Wingerchuk; Joseph I Sirven
Remission, intractability, and antiepileptic-drug withdrawal.
Lancet neurology 2005;4(7):390-1.
2005: Dean M Wingerchuk; E E Benarroch; P C O'Brien; B Mark Keegan; Claudia F Lucchinetti; John H Noseworthy; B G Weinshenker; M Rodriguez
A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis.
Neurology 2005;64(7):1267-9.
2004: Vanda A Lennon; Dean M Wingerchuk; Thomas J Kryzer; Sean J Pittock; Claudia F Lucchinetti; Kazuo Fujihara; Ichiro Nakashima; Brian G Weinshenker
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.
Lancet 2004;364(9451):2106-12.
2004: Joseph I Sirven; Dean M Wingerchuk; Joseph F Drazkowski; Mark K Lyons; Richard S Zimmerman
Seizure prophylaxis in patients with brain tumors: a meta-analysis.
Mayo Clinic proceedings. Mayo Clinic 2004;79(12):1489-94.
2004: Dean M Wingerchuk
Cannabis for medical purposes: cultivating science, weeding out the fiction.
Lancet 2004;364(9431):315-6.
2004: Dean M Wingerchuk
Neuromyelitis optica: current concepts.
Frontiers in bioscience : a journal and virtual library 2004;9():834-40.
2003: Dean M Wingerchuk; Jonathan L Carter
Practical consultations: multiple sclerosis.
Seminars in neurology 2003;23(3):253-64.
2003: Dean M Wingerchuk
Postinfectious encephalomyelitis.
Current neurology and neuroscience reports 2003;3(3):256-64.
2003: Dean M Wingerchuk; Brian G Weinshenker
Neuromyelitis optica: clinical predictors of a relapsing course and survival.
Neurology 2003;60(5):848-53.
2002: Claudia F Lucchinetti; Raul N Mandler; Dorian B McGavern; Wolfgang Bruck; Gerald Gleich; Richard M Ransohoff; Corinna Trebst; Brian G Weinshenker; Dean M Wingerchuk; Joseph E Parisi; Hans Lassmann
A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.
Brain : a journal of neurology 2002;125(Pt 7):1450-61.
2002: Joseph I Sirven; D W Claypool; K L Sahs; Dean M Wingerchuk; Jennifer J Bortz; Joseph F Drazkowski; Richard Caselli; D Zanick
Is there a neurologist on this flight?
Neurology 2002;58(12):1739-44.
2002: Dean M Wingerchuk; John H Noseworthy
Randomized controlled trials to assess therapies for multiple sclerosis.
Neurology 2002;58(8 Suppl 4):S40-8.
2001: John H Noseworthy; Peter C O'Brien; Tanya M Petterson; J Weis; L Stevens; W K Peterson; D Sneve; S A Cross; Jacqueline A Leavitt; Raymond G Auger; Brian G Weinshenker; D W Dodick; Dean M Wingerchuk; Moses Rodriguez
A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis.
Neurology 2001;56(11):1514-22.
2001: Dean M Wingerchuk; Claudia F Lucchinetti; John H Noseworthy
Multiple sclerosis: current pathophysiological concepts.
Laboratory investigation; a journal of technical methods and pathology 2001;81(3):263-81.
1999: Dean M Wingerchuk; W F Hogancamp; Peter C O'Brien; Brian G Weinshenker
The clinical course of neuromyelitis optica (Devic's syndrome).
Neurology 1999;53(5):1107-14.
1999: Dean M Wingerchuk; Brian G Weinshenker
The natural history of multiple sclerosis: implications for trial design.
Current opinion in neurology 1999;12(3):345-9.
1999: Brian G Weinshenker; David D Hebrink; Dean M Wingerchuk; Christopher J Klein; E Atkinson; Peter C O'Brien; Cynthia T McMurray
Genetic variants in the tumor necrosis factor receptor 1 gene in patients with MS.
Neurology 1999;52(7):1500-3.
1998: Dean M Wingerchuk; John H Noseworthy; David W Kimmel
Paraneoplastic encephalomyelitis and seminoma: importance of testicular ultrasonography.
Neurology 1998;51(5):1504-7.
1998: Dean M Wingerchuk; Eelco F M Wijdicks; Jimmy R Fulgham
Cerebral venous thrombosis complicated by hemorrhagic infarction: factors affecting the initiation and safety of anticoagulation.
Cerebrovascular diseases (Basel, Switzerland) 1998;8(1):25-30.
1997: Dean M Wingerchuk; John H Noseworthy; BG Weinshenker
Clinical outcome measures and rating scales in multiple sclerosis trials.
Mayo Clinic proceedings. Mayo Clinic 1997;72(11):1070-9.
1997: Dean M Wingerchuk; K N Krecke; Jimmy R Fulgham
Multifocal brain MRI artifacts secondary to embolic metal fragments.
Neurology 1997;49(5):1451-3.
1997: Dean M Wingerchuk; Q Liu; J Sobell; S Sommer; Brian G Weinshenker
A population-based case-control study of the tumor necrosis factor alpha-308 polymorphism in multiple sclerosis.
Neurology 1997;49(2):626-8.
1997: Brian G Weinshenker; Dean M Wingerchuk; Q Liu; A S Bissonet; D J Schaid; S S Sommer
Genetic variation in the tumor necrosis factor alpha gene and the outcome of multiple sclerosis.
Neurology 1997;49(2):378-85.